NRAS-Q Real-Time PCR Kit

Overview


Mutations in the NRAS gene play a critical role in the development and progression of several cancers, most notably melanoma and colorectal cancer. Found in 15 - 25% of melanomas and 2 - 6% of colorectal tumors, NRAS mutations are associated with resistance to targeted therapies and are recognized as negative prognostic markers in various cancers. Given their impact on treatment outcomes, accurate detection of these mutations is now a crucial part of precision oncology and clinical decision-making.

To address this need, Genes2Me presents the NRAS-Q Real-Time PCR Kit, an advanced in vitro diagnostic solution designed for the sensitive and specific detection of nine clinically significant NRAS mutations across codons 12, 13, 59, 61, 117, and 146 in exons 2, 3, and 4. The kit is validated for use with FFPE and fresh clinical samples, making it an ideal tool for both routine diagnostics and advanced molecular oncology applications.

The NRAS-Q Real-Time PCR kit uses allele-specific PCR with mutation-targeted FAM probes and an integrated HEX-labeled internal control to deliver precise, reliable mutation detection while continuously monitoring DNA quality and PCR performance. A streamlined workflow with seven ready-to-use mixes, including controls, ensures consistent results, high reproducibility, and minimal hands-on time.

Clinical Utility


NRAS-Q
  • Colorectal Cancer Stratification: Enables detection of NRAS mutations in KRAS wild-type patients, supporting informed treatment selection and ruling out resistance to EGFR-targeted therapies.
  • Melanoma Prognosis & Targeting: Identifies NRAS mutations as negative prognostic markers and emerging therapeutic targets, guiding novel treatment strategies.
  • Precision Oncology: Helps clinicians personalize treatment plans and improve patient outcomes by integrating molecular profiling into routine practice.

The NRAS-Q Real-Time PCR Kit empowers laboratories and oncologists with a robust, clinically validated, and easy-to-use solution for mutation detection. By providing accurate insights into NRAS mutation status, it helps optimize cancer treatment strategies and supports the global shift towards personalized oncology care.

Key Features & Benefits


Comprehensive NRAS Coverage

Detects nine clinically relevant NRAS mutations for confident molecular profiling.

Precision Oncology Ready

A robust, clinically validated, and easy-to-use solution that enables accurate NRAS mutation assessment, supports optimized treatment decisions, and advances personalized oncology care.

Built-In Quality Assurance

Integrated process control continuously monitors assay performance, ensuring accurate and reproducible results.

High Sensitivity & Specificity

Enables reliable detection of low-frequency variants, even in challenging samples.

Broad Platform Compatibility

Validated on leading real-time PCR systems, including Thermo Fisher QuantStudio™ 5, Bio-Rad CFX96, Roche LightCycler® 480, and Genes2Me RapiCycler 96.

User-Friendly Workflow

Pre-mixed, ready-to-use reagents simplify assay setup, reduce hands-on time, and minimize user error.

Ordering Information


Commercial Name Cat No. Pack Size
NRAS-Q Real-Time PCR Kit G610023 25T

Resources to get started


Download useful documents and technical information of NRAS-Q Real-Time PCR Kit.

Product Enquiry Form


Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.


© 2025 Genes2me. All rights reserved.